Spade-Shaped Anastomosis After Laparoscopic or Robotic Proximal Gastrectomy Using Double Suture Anchoring Between the Posterior Wall of the Esophagus and the Anterior Wall of the Stomach (SPADE Operation): a Multicenter Prospective Clinical Trial.
Background: While proximal gastrectomy (removing only the upper part of the stomach) offers nutritional advantages over total gastrectomy, it often leads to significant postoperative reflux esophagitis * The SPADE technique was developed to prevent this by creating an artificial anti-reflux mechanism (angle of His and pseudo-fornix) using double suture anchoring between the esophagus and the stomach Study Plan: Participants: The study will enroll approximately 159 patients with tumors (size ≤ 4 cm) located in the upper third of the stomach who are eligible for gastric function-preserving surgery . Intervention: All participants will undergo laparoscopic or robotic proximal gastrectomy followed by the SPADE reconstruction method . Primary
Objective: The primary goal is to determine the incidence of endoscopic reflux esophagitis at one year postoperatively . Secondary
Objectives: Investigators will also monitor postoperative reflux symptoms, nutritional parameters (such as weight, hemoglobin, and vitamin B12 levels), surgical complications, quality of life, and 3-year survival rates . Hypothesis: The researchers hypothesize that the SPADE operation is a safe and effective surgical approach that can provide equivalent reflux prevention (a target rate of approximately 2.9%) compared to existing complex reconstruction methods, while maintaining the benefits of preserving gastric function
∙ ① Histologically confirmed diagnosis of gastric adenocarcinoma by biopsy.
• Adult patients aged 20 years or older.
⁃ Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2.
⁃ ④ American Society of Anesthesiologists (ASA) physical status classification of class I to III.
⁃ ⑤ Patients who have received a full explanation of the study purpose and procedures, and voluntarily signed the informed consent form approved by the Institutional Review Board.
⁃ ⑥ Patients eligible for proximal gastrectomy satisfying the following oncologic characteristics on preoperative evaluation:
⁃ • Tumor location: Upper third of the stomach (High body, cardia, fundus, gastroesophageal junction \[Siewert III\])
‣ Tumor size: 4 cm or less
‣ Preoperative clinical stage: T1N0, T1N1, T2N0, T2N1 (any differentiation)
‣ Preoperative clinical stage: T3N0, T3N1 (well or moderate differentiation)
‣ Expected residual stomach: 60% or more after surgery